(Allergan plc)

	AGN latest price $135.3525 (0.14%) ($133.9400 - $138.5058) on Thu. Jan. 3, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2% (three month average)
RSI	23
Latest Price	$135.3525(0.14%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.4% a day on average for past five trading days.
Weekly Trend	AGN declines -5% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(49%)    ARKG(46%)    XLV(46%)    XBI(45%)    IVE(44%)
Factors Impacting AGN price	AGN will decline at least -1% in a week (0% probabilities).   VIXM(-25%)    TLT(-23%)    DIA(-21%)    UUP(-20%)    VXX(-15%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1% (StdDev 2%)
Hourly BBV	0 ()
Intraday Trend	0.2%

Resistance Level	$141.16
5 Day Moving Average	$133.51(1.38%)
10 Day Moving Average	$133.11(1.68%)
20 Day Moving Average	$141.16(-4.11%)
To recent high	-29.4%
To recent low	4.8%
Market Cap	$44.626b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed